Key facts
- This page summarizes New Enterprise Associates 17, L.P.'s Form 4 filing for SpyGlass Pharma, Inc. (SGP).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 11 Feb 2026, 16:30.
New Enterprise Associates 17, L.P. - 09 Feb 2026 Form 4 Insider Report for SpyGlass Pharma, Inc. (SGP)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- SGP
- Reported as of
- 09 Feb 2026
- Net transaction value
- +$15,000,000
- SEC form
- 4
- Accepted by SEC
- 11 Feb 2026, 16:30:17 UTC
- Prior SEC filing
- 05 Feb 2026
- Next SEC filing
- 12 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Zachary Bambach, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
New Enterprise Associates 17, L.P. filed Form 4 for SpyGlass Pharma, Inc. (SGP) on 11 Feb 2026.
Change
- Previous filing in this sequence was filed on 05 Feb 2026.
- Current net transaction value: +$15,000,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (3)
CIK 0001768564
Primary reporting owner
New Enterprise Associates 17, L.P.
- Relationship
- 10%+ Owner
- Address
- 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM
- Signature
- /s/ Zachary Bambach, attorney-in-fact
- Signature date
- 11 Feb 2026
CIK 0001796820
NEA Partners 17, L.P.
- Relationship
- 10%+ Owner
- Address
- 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM
- Signature
- /s/ Zachary Bambach, attorney-in-fact
- Signature date
- 11 Feb 2026
CIK 0001796821
NEA 17 GP, LLC
- Relationship
- 10%+ Owner
- Address
- 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM
- Signature
- /s/ Zachary Bambach, attorney-in-fact
- Signature date
- 11 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGP
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,619,240
- Change %
- Price
- Shares after
- 1,619,240
- Date
- 09 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2
SGP
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,370,168
- Change %
- +85%
- Price
- Shares after
- 2,989,408
- Date
- 09 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2
SGP
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,370,168
- Change %
- +46%
- Price
- Shares after
- 4,359,576
- Date
- 09 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2
SGP
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +737,962
- Change %
- +17%
- Price
- Shares after
- 5,097,538
- Date
- 09 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2
SGP
transaction
Common Stock
Purchase
- Transaction value
- $15,000,000
- Shares
- +937,500
- Change %
- +18%
- Price
- $16.00
- Shares after
- 6,035,038
- Date
- 09 Feb 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SGP
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,619,240
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 09 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,619,240
- Exercise price
- Footnotes
- F1, F2
SGP
transaction
Derivative
Series C-1 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,370,168
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 09 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,370,168
- Exercise price
- Footnotes
- F1, F2
SGP
transaction
Derivative
Series C-2 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,370,168
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 09 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,370,168
- Exercise price
- Footnotes
- F1, F2
SGP
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -737,962
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 09 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 737,962
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
All shares of the preferred stock, par value $0.00001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), prior to the closing of the Issuer's initial public offering of its Common Stock on February 9, 2026.
Footnote F2
The securities are directly held by New Enterprise Associates 17, L.P. ("NEA 17") and are indirectly held by NEA Partners 17, L.P. ("NEA Partners 17"), the sole general partner of NEA 17, NEA 17 GP, LLC ("NEA 17 GP"), the sole general partner of NEA Partners 17, and the individual managers of NEA 17 GP (NEA Partners 17, NEA 17 GP and the individual managers of NEA 17 GP (collectively, the "Managers") together, the "Indirect Reporting Persons"). The Mangers are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott Sandell, Paul Walker and Rick Yang. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Indirect Reporting Persons have no pecuniary interest.